期刊文献+

半乳糖凝集素-1、p16蛋白表达与宫颈癌患者临床特征的关系 被引量:3

Association between galectin-1 and p16 protein expression and clinical characteristics of cervical cancer
下载PDF
导出
摘要 目的探讨宫颈癌组织中半乳糖凝集素-1(Gal-1)、p16蛋白的表达情况及与宫颈癌患者临床特征的关系.方法选取100例宫颈癌患者的宫颈癌组织标本和100例宫颈上皮瘤变(CIN)患者的CIN组织标本.采用免疫组织化学染色法检测宫颈癌组织、CIN组织中Gal-1、p16蛋白的表达情况,并分析Gal-1、p16蛋白表达与宫颈癌患者临床特征的关系.结果宫颈癌组织中Gal-1、p16蛋白的阳性表达率均明显高于CIN组织(P﹤0.01);国际妇产科联盟(FIGO)分期为Ⅲ~Ⅳ期、有淋巴结转移、肿瘤分化程度为低分化的宫颈癌患者宫颈癌组织中Gal-1蛋白阳性表达率高于FIGO分期为Ⅰ~Ⅱ期、无淋巴结转移、肿瘤分化程度为中高分化的患者(P﹤0.05);肿瘤分化程度为低分化的宫颈癌患者宫颈癌组织中p16蛋白的阳性表达率明显高于肿瘤分化程度为中高分化的患者(P﹤0.01).结论宫颈癌组织中Gal-1、p16蛋白的表达上调,并且与宫颈癌的恶性程度有一定的关系. Objective To investigate the associations between the expression of galectin-1 (Gal-1) and p16 protein and clinical characteristics of patients with cervical cancer. Method Cervical cancer tissue samples from 100 patients with cervical cancer and cervical intraepithelial neoplasia (CIN) tissue samples from 100 patients with CIN were collected. Immunohistochemical staining was employed to detect the expression of Gal-1 and p16 in tissues from both cervical cancer and CIN patients, and the relationship between Gal-1 and p16 expression and clinical features of cervical cancer patients was analyzed. Result The positive rate of Gal-1 and p16 in cervical cancer tissues were significantly higher than those in CIN tissues (P<0.01). The positive rate of Gal-1 in cervical cancer tissues with International Federation of Gynecology and Obstetrics (FIGO) stage III-IV stage, lymph node metastasis and poorly differentiated is significantly higher than that from tissues with FIGO stage I-II stage, no lymph node metastasis, and well differentiated (P<0.05);The positive rate of p16 in cervical cancer tissues from patients with poorly differentiated cervical cancer was significantly higher than that in patients with well differentiated tissues (P<0.01). Conclusion Gal-1 and p16 expression is up-regulated in cervical cancer tissues and relate to the malignancy of cervical cancer to some extent.
作者 江娜 王秀虹 JIANG Na;WANG Xiuhong(Department of Gynaecology, Xianning City Central Hospital First Affiliated Hospital of Hubei Institute of Science and Technology,Xianning 437100, Hubei, China)
出处 《癌症进展》 2019年第14期1707-1709,共3页 Oncology Progress
关键词 宫颈癌 半乳糖凝集素-1 P16蛋白 cervical cancer galectin-1 p16 protein
  • 相关文献

参考文献12

二级参考文献80

  • 1时广利,胡秀玲,岳思东,宋长兴.血清肿瘤标志物在肺癌辅助诊断中的应用[J].中华肿瘤杂志,2005,27(5):299-301. 被引量:82
  • 2姚群峰,宁勇,张利平,周宜开.血清p16基因甲基化联合CYFRA21-1检测在肺癌诊断中的应用[J].微循环学杂志,2006,16(1):29-31. 被引量:8
  • 3汪亚松,金永堂,薛绍礼,于在诚,徐迎春,刘晓,田敏华,陶文虎,孔云明,侯勇.p16基因甲基化在非小细胞肺癌发病中的研究[J].安徽医科大学学报,2006,41(6):619-622. 被引量:9
  • 4Yang RY, Rabinovich GA, Liu FT. Galcctins: slrUCRLrC, function and therapeutic potential [J]. Expert Rcv Mol Mcd, 2008, 10: e17.
  • 5Zhao XY, Chela TT, Xia L, et al. Hypoxia inducible factor-Ⅰ medi- ates expression of galectin-l: the potential role in migration/inva- sion of colorectalcancer cells [J]. Carcinogenesis, 2010, 31(8): 1367-1375.
  • 6Croci DO, Salatino M, Rubinstein N, et al. Disrupting galectin-I in- teractions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma [J]. J Exp Mcd, 2012, 209 (11): 1985-2000.
  • 7Thijssen VL, Barkan B, Shoji H, et al. Tumor cells secrete galec- tin-1 to enhance endothelial cell activity [J]. Cancer Rcs, 2010, 70 (15): 6216-6224.
  • 8Wu MH, Hong TM, Cheng HW, et al. Galectin-l-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase ex- pression, and reorganized actin cytoskeletons [J]. Mol Cancer Res, 2009, 7(3): 311-318.
  • 9Dalotto-Moreno T, Croci DO, Cerliani JP, et al. Targeting galectin-I breast cancer associated immunosuppression and pro- vents metastatic disease [J]. Cancer Rcs, 2013, 73(3): 1107-1117.
  • 10Watanabc M, Takemasa I, Kaneko N, et al. Clinical significance of circulating galectins as colorectal cancer markers [J]. Oncology Re- ports, 2011, 25(5): 1217-1226.

共引文献147

同被引文献31

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部